British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against Covid-19 has shown "an average efficacy of 70 percent" in trials."This vaccine's efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency," AstraZeneca chief executive Pascal Soriot said in a statement.However the vaccine has produced lower average efficacy compared with coronavirus vaccines produced by rivals Pfizer/BioNTech and Moderna which have come in above 90 percent.
Monday, November 23, 2020
AstraZeneca/Oxford say Covid vaccine shows 70% efficacy | Economic Times
Subscribe to:
Post Comments (Atom)
-
NSE IFSC-SGX Connect may be fully operational by June https://ift.tt/XC89Iks this connectivity, global investors who are clients of SGX will...
-
India likely to benefit from slump in Hong Kong market https://ift.tt/yH6rjid Several overseas institutional investors have pruned exposure ...
-
Tough challenges await Rishi Sunak: Tory strategists https://ift.tt/ibXqIld has successfully eaten into the opposition poll lead - Keir Star...
No comments:
Post a Comment